Amalgamation
As filed · Amalgamation/Merger
What happened
FactAmalgamation/Merger. Amalgamation between Subsidiary Companies. The said Scheme of Amalgamation is not expected to have any material impact on the financials.
Why it matters
CapitSignal interpretationA merger fixes a share-exchange ratio, which permanently sets how much of the combined company existing holders own.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
DelayedWhen we look at the VAM VAE plant, some of the activities around that possibly will come to fruition in quarter one of next year as we see it today.
In FY 2025-26, we commissioned our White Cement plant in Fujairah, UAE.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Swap ratio and its valuation basis
- Regulatory and NCLT approvals required
- Appointed date
- When we look at the VAM VAE plant, some of the activities around that possibly will come to fruition in quarte (management committed by Q1 FY27)
- So, we are still hopeful that possibly a larger retailing season should be September as we go ahead and look a (management committed by Q2 FY26)
Evidence
- Board of Directors of Harind Chemicals and Pharmaceuticals Private Limited ( Harind ), a subsidiary of the Company, and Nova Surface-Care Centre Private Limited ( Nova ), a wholly-owned subsidiary of Harind, at their respective meetings held today i.e., Tuesday, 24th March 2026, have, inter alia, approved the Scheme of Amalgamation of Nova ( Transferor Company ) with Harind ("Transferee Company").(opens the original filing in a new tab)
- Earlier statement · Q1 FY26
- Latest statement · FY26
How CapitSignal classified this
- Reasoning:
- MERGER base 74; +2 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%